Chattergoon MA - Search Results

1

Systemic and mucosal immunity is elicited after both intramuscular and intravaginal delivery of human immunodeficiency virus type 1 DNA plasmid vaccines to pregnant chimpanzees.

Bagarazzi ML, Boyer JD, Javadian MA, Chattergoon MA, Shah AR, Cohen AD, Bennett MK, Ciccarelli RB, Ugen KE, Weiner DB. Bagarazzi ML, et al. Among authors: chattergoon ma. J Infect Dis. 1999 Oct;180(4):1351-5. doi: 10.1086/314978. J Infect Dis. 1999. PMID: 10479171

2

Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination.

Boyer JD, Ugen KE, Wang B, Agadjanyan M, Gilbert L, Bagarazzi ML, Chattergoon M, Frost P, Javadian A, Williams WV, Refaeli Y, Ciccarelli RB, McCallus D, Coney L, Weiner DB. Boyer JD, et al. Nat Med. 1997 May;3(5):526-32. doi: 10.1038/nm0597-526. Nat Med. 1997. PMID: 9142121

3

Safety and immunogenicity of intramuscular and intravaginal delivery of HIV-1 DNA constructs to infant chimpanzees.

Bagarazzi ML, Boyer JD, Javadian MA, Chattergoon M, Dang K, Kim G, Shah J, Wang B, Weiner DB. Bagarazzi ML, et al. Among authors: chattergoon m. J Med Primatol. 1997 Feb-Apr;26(1-2):27-33. doi: 10.1111/j.1600-0684.1997.tb00316.x. J Med Primatol. 1997. PMID: 9271186

4

DNA vaccination as anti-human immunodeficiency virus immunotherapy in infected chimpanzees.

Boyer JD, Ugen KE, Chattergoon M, Wang B, Shah A, Agadjanyan M, Bagarazzi ML, Javadian A, Carrano R, Coney L, Williams WV, Weiner DB. Boyer JD, et al. J Infect Dis. 1997 Dec;176(6):1501-9. doi: 10.1086/514148. J Infect Dis. 1997. PMID: 9395361

5

Induction of a TH1 type cellular immune response to the human immunodeficiency type 1 virus by in vivo DNA inoculation.

Boyer J, Ugen K, Wang B, Chattergoon M, Tsai A, Merva M, Weiner DB. Boyer J, et al. Dev Biol Stand. 1998;92:169-74. Dev Biol Stand. 1998. PMID: 9554272

6

Safety and immunogenicity of HIV-1 DNA constructs in chimpanzees.

Bagarazzi ML, Boyer JD, Ugen KE, Javadian MA, Chattergoon M, Shah A, Bennett M, Ciccarelli R, Carrano R, Coney L, Weiner DB. Bagarazzi ML, et al. Among authors: chattergoon m. Vaccine. 1998 Nov;16(19):1836-41. doi: 10.1016/s0264-410x(98)00178-9. Vaccine. 1998. PMID: 9795389 Free article.

7

HIV-1 DNA based vaccine induces a CD8 mediated cross-clade CTL response.

Boyer JD, Chattergoon M, Shah A, Ginsberg R, MacGregor RR, Weiner DB. Boyer JD, et al. Dev Biol Stand. 1998;95:147-53. Dev Biol Stand. 1998. PMID: 9855425 Clinical Trial.

8

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response.

MacGregor RR, Boyer JD, Ugen KE, Lacy KE, Gluckman SJ, Bagarazzi ML, Chattergoon MA, Baine Y, Higgins TJ, Ciccarelli RB, Coney LR, Ginsberg RS, Weiner DB. MacGregor RR, et al. Among authors: chattergoon ma. J Infect Dis. 1998 Jul;178(1):92-100. doi: 10.1086/515613. J Infect Dis. 1998. PMID: 9652427 Clinical Trial.

9

Next generation DNA vaccines for HIV-1.

Boyer JD, Chattergoon M, Muthumani K, Kudchodkar S, Kim J, Bagarazzi M, Pavlakis G, Sekaly R, Weiner DB. Boyer JD, et al. J Liposome Res. 2002 Feb-May;12(1-2):137-42. doi: 10.1081/lpr-120004786. J Liposome Res. 2002. PMID: 12604047 Review.

10

Development of a multicomponent candidate vaccine for HIV-1.

Kim JJ, Ayyavoo V, Bagarazzi ML, Chattergoon M, Boyer JD, Wang B, Weiner DB. Kim JJ, et al. Vaccine. 1997 Jun;15(8):879-83. doi: 10.1016/s0264-410x(96)00260-5. Vaccine. 1997. PMID: 9234538 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page